Data as of Oct 24
| +0.38 / +0.84%|
The 3 analysts offering 12-month price forecasts for West Pharmaceutical Services Inc have a median target of 50.00, with a high estimate of 50.00 and a low estimate of 45.00. The median estimate represents a +9.94% increase from the last price of 45.48.
The current consensus among 3 polled investment analysts is to Buy stock in West Pharmaceutical Services Inc. This rating has held steady since October, when it was upgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.